Biochemical and Biophysical Research Communications, ISSN 0006-291X, 01/2019, Volume 509, Issue 1, pp. 262 - 267
High levels of glutamate dehydrogenase (GDH) activity are associated with hypoglycemia, cancer, and Parkinson's disease. Propylselen was synthesized to...
Glutamate dehydrogenase | Propylselen | Biomolecular interaction assay | Inhibitors | Enzyme kinetics | EGCG | ALLOSTERIC REGULATION | ENZYME | BIOPHYSICS | GLUTAMINASE | BIOCHEMISTRY & MOLECULAR BIOLOGY | HYPERINSULINISM
Glutamate dehydrogenase | Propylselen | Biomolecular interaction assay | Inhibitors | Enzyme kinetics | EGCG | ALLOSTERIC REGULATION | ENZYME | BIOPHYSICS | GLUTAMINASE | BIOCHEMISTRY & MOLECULAR BIOLOGY | HYPERINSULINISM
Journal Article
Journal of Physiology and Biochemistry, ISSN 1138-7548, 11/2018, Volume 74, Issue 4, pp. 667 - 677
The adrenomedullary chromaffin cells' hormonal pathway has been related to the pathophysiology of diabetes mellitus. In mice, the deletion of insulin receptor...
Glycerol release | Dopamine | Beta-cells | Adrenal chromaffin cells | Tyrosine hydroxylase | Adipocytes | Proliferation | Apoptosis | Insulin secretion | PHYSIOLOGY | BIOCHEMISTRY & MOLECULAR BIOLOGY | NEUROENDOCRINE | CATECHOLAMINE SECRETION | DIABETIC-NEUROPATHY | DEFICIENCY | HYPOGLYCEMIA | NEURONS | PROTEINS | Prediabetic State - metabolism | Adrenal Medulla - metabolism | Tyrosine 3-Monooxygenase - metabolism | Chromaffin Cells - enzymology | Chromaffin Cells - pathology | Male | Insulin Receptor Substrate Proteins - metabolism | Islets of Langerhans - metabolism | Female | Prediabetic State - pathology | Insulin Receptor Substrate Proteins - genetics | Hyperinsulinism - blood | Insulin Secretion | Dopamine - metabolism | Hyperinsulinism - metabolism | Prediabetic State - blood | Adrenal Medulla - pathology | Islets of Langerhans - pathology | Tissue Culture Techniques | Mice, Inbred C57BL | Cells, Cultured | Organ Size | Adrenal Medulla - enzymology | Sex Characteristics | Lipolysis | Mice, Knockout | Hyperinsulinism - pathology | Chromaffin Cells - metabolism | Adipocytes, White - pathology | Animals | In Vitro Techniques | Adipocytes, White - metabolism | Immunohistochemistry | Tyrosine | Analysis | Phenols | Insulin resistance | Diabetes | Cells
Glycerol release | Dopamine | Beta-cells | Adrenal chromaffin cells | Tyrosine hydroxylase | Adipocytes | Proliferation | Apoptosis | Insulin secretion | PHYSIOLOGY | BIOCHEMISTRY & MOLECULAR BIOLOGY | NEUROENDOCRINE | CATECHOLAMINE SECRETION | DIABETIC-NEUROPATHY | DEFICIENCY | HYPOGLYCEMIA | NEURONS | PROTEINS | Prediabetic State - metabolism | Adrenal Medulla - metabolism | Tyrosine 3-Monooxygenase - metabolism | Chromaffin Cells - enzymology | Chromaffin Cells - pathology | Male | Insulin Receptor Substrate Proteins - metabolism | Islets of Langerhans - metabolism | Female | Prediabetic State - pathology | Insulin Receptor Substrate Proteins - genetics | Hyperinsulinism - blood | Insulin Secretion | Dopamine - metabolism | Hyperinsulinism - metabolism | Prediabetic State - blood | Adrenal Medulla - pathology | Islets of Langerhans - pathology | Tissue Culture Techniques | Mice, Inbred C57BL | Cells, Cultured | Organ Size | Adrenal Medulla - enzymology | Sex Characteristics | Lipolysis | Mice, Knockout | Hyperinsulinism - pathology | Chromaffin Cells - metabolism | Adipocytes, White - pathology | Animals | In Vitro Techniques | Adipocytes, White - metabolism | Immunohistochemistry | Tyrosine | Analysis | Phenols | Insulin resistance | Diabetes | Cells
Journal Article
Journal of Diabetes Research, ISSN 2314-6745, 2017, Volume 2017, pp. 3601708 - 10
Type 2 diabetes mellitus (T2DM) is a metabolic disorder that severely affects human health, but the pathogenesis of the disease remains unknown. The...
C-REACTIVE PROTEIN | MEDICINE, RESEARCH & EXPERIMENTAL | HIGH-FAT | METABOLISM | INSULIN-RESISTANCE | ACID-BINDING PROTEIN | ENDOCRINOLOGY & METABOLISM | RISK | GLUCOKINASE | TYPE-2 DIABETES-MELLITUS | GLUCOSE-TOLERANCE | LIVER FAT | Liver - pathology | Liver - enzymology | Kidney - pathology | Gene Expression Profiling | Macaca mulatta | Chromatography, High Pressure Liquid | Diabetes Mellitus, Type 2 - metabolism | Tandem Mass Spectrometry | Spectrometry, Mass, Electrospray Ionization | Hyperinsulinism - etiology | Peptide Mapping | Female | Obesity - etiology | Proteomics - methods | Real-Time Polymerase Chain Reaction | Diabetes Mellitus, Type 2 - complications | Hyperlipidemias - complications | Hyperinsulinism - metabolism | Hyperinsulinism - complications | Hyperlipidemias - metabolism | Obesity - complications | Liver - metabolism | Computational Biology | Insulin Resistance | Pancreas - pathology | Reverse Transcriptase Polymerase Chain Reaction | Diet, Western - adverse effects | Obesity - metabolism | Obesity - pathology | Gene Expression Regulation - drug effects | Hyperinsulinism - pathology | Animals | Hyperlipidemias - etiology | Hyperlipidemias - pathology | Diabetes Mellitus, Type 2 - pathology
C-REACTIVE PROTEIN | MEDICINE, RESEARCH & EXPERIMENTAL | HIGH-FAT | METABOLISM | INSULIN-RESISTANCE | ACID-BINDING PROTEIN | ENDOCRINOLOGY & METABOLISM | RISK | GLUCOKINASE | TYPE-2 DIABETES-MELLITUS | GLUCOSE-TOLERANCE | LIVER FAT | Liver - pathology | Liver - enzymology | Kidney - pathology | Gene Expression Profiling | Macaca mulatta | Chromatography, High Pressure Liquid | Diabetes Mellitus, Type 2 - metabolism | Tandem Mass Spectrometry | Spectrometry, Mass, Electrospray Ionization | Hyperinsulinism - etiology | Peptide Mapping | Female | Obesity - etiology | Proteomics - methods | Real-Time Polymerase Chain Reaction | Diabetes Mellitus, Type 2 - complications | Hyperlipidemias - complications | Hyperinsulinism - metabolism | Hyperinsulinism - complications | Hyperlipidemias - metabolism | Obesity - complications | Liver - metabolism | Computational Biology | Insulin Resistance | Pancreas - pathology | Reverse Transcriptase Polymerase Chain Reaction | Diet, Western - adverse effects | Obesity - metabolism | Obesity - pathology | Gene Expression Regulation - drug effects | Hyperinsulinism - pathology | Animals | Hyperlipidemias - etiology | Hyperlipidemias - pathology | Diabetes Mellitus, Type 2 - pathology
Journal Article
Scientific Reports, ISSN 2045-2322, 12/2017, Volume 7, Issue 1, pp. 14876 - 9
Disruption of insulin secretion and clearance both contribute to obesity-induced hyperinsulinemia, though reduced insulin clearance seems to be the main...
METABOLIC SYNDROME | ALZHEIMERS-DISEASE | GLUCOSE | MULTIDISCIPLINARY SCIENCES | RESISTANCE | FAT | BARIATRIC SURGERY | HYPERINSULINEMIA | DEGRADATION | INHIBITORS | SECRETION | Insulysin - metabolism | Liver - enzymology | Humans | Liver - metabolism | Hyperinsulinism - drug therapy | Hep G2 Cells | Taurochenodeoxycholic Acid - pharmacology | Insulysin - drug effects | Animals | Diet, High-Fat | Mice, Obese | Mice | Insulin - pharmacokinetics | Taurine | Hyperinsulinemia | Obesity | Enzymes | Secretion | Liver | Insulysin | AKT protein | Insulin | Bile | High fat diet | 1-Phosphatidylinositol 3-kinase
METABOLIC SYNDROME | ALZHEIMERS-DISEASE | GLUCOSE | MULTIDISCIPLINARY SCIENCES | RESISTANCE | FAT | BARIATRIC SURGERY | HYPERINSULINEMIA | DEGRADATION | INHIBITORS | SECRETION | Insulysin - metabolism | Liver - enzymology | Humans | Liver - metabolism | Hyperinsulinism - drug therapy | Hep G2 Cells | Taurochenodeoxycholic Acid - pharmacology | Insulysin - drug effects | Animals | Diet, High-Fat | Mice, Obese | Mice | Insulin - pharmacokinetics | Taurine | Hyperinsulinemia | Obesity | Enzymes | Secretion | Liver | Insulysin | AKT protein | Insulin | Bile | High fat diet | 1-Phosphatidylinositol 3-kinase
Journal Article
Pancreatology, ISSN 1424-3903, 11/2017, Volume 17, Issue 6, pp. 876 - 883
While the close morphological relationship between the exocrine and endocrine pancreas is well established, their functional interaction remains poorly...
Insulo-acinar axis | Chymotrypsin | Trypsin | Pancreatic hormones | Insulin | ISLET BLOOD-FLOW | CATIONIC TRYPSIN | ENDOCRINE | RATS | RECEPTOR DOWN-REGULATION | EXOCRINE PANCREAS | ABDOMINAL OBESITY | GLUCOSE-METABOLISM | INSULIN-RESISTANCE | SCANNING-ELECTRON-MICROSCOPY | GASTROENTEROLOGY & HEPATOLOGY | Diabetes Mellitus - blood | Cross-Sectional Studies | Humans | Middle Aged | Diabetes Mellitus - metabolism | Male | Insulin - blood | Pancreatitis - enzymology | Chymotrypsin - blood | Pancreatitis - blood | Trypsin - blood | Adult | Female | Aged | Hyperinsulinism - blood | Pancreas - enzymology | Enzymes | Pancreatic hormone | Polypeptides | Metabolic diseases | Dosage and administration | Research | Health aspects | Hyperinsulinemia | Statistical analysis | Glucagon | Proteolytic enzymes | Diabetes mellitus | Pancreatitis | Hormones | Glucose | Studies | Body mass index | Proteolysis | Rodents | Mathematical models | Somatostatin | Smoking
Insulo-acinar axis | Chymotrypsin | Trypsin | Pancreatic hormones | Insulin | ISLET BLOOD-FLOW | CATIONIC TRYPSIN | ENDOCRINE | RATS | RECEPTOR DOWN-REGULATION | EXOCRINE PANCREAS | ABDOMINAL OBESITY | GLUCOSE-METABOLISM | INSULIN-RESISTANCE | SCANNING-ELECTRON-MICROSCOPY | GASTROENTEROLOGY & HEPATOLOGY | Diabetes Mellitus - blood | Cross-Sectional Studies | Humans | Middle Aged | Diabetes Mellitus - metabolism | Male | Insulin - blood | Pancreatitis - enzymology | Chymotrypsin - blood | Pancreatitis - blood | Trypsin - blood | Adult | Female | Aged | Hyperinsulinism - blood | Pancreas - enzymology | Enzymes | Pancreatic hormone | Polypeptides | Metabolic diseases | Dosage and administration | Research | Health aspects | Hyperinsulinemia | Statistical analysis | Glucagon | Proteolytic enzymes | Diabetes mellitus | Pancreatitis | Hormones | Glucose | Studies | Body mass index | Proteolysis | Rodents | Mathematical models | Somatostatin | Smoking
Journal Article
Applied Physiology, Nutrition, and Metabolism, ISSN 1715-5312, 2017, Volume 42, Issue 9, pp. 963 - 972
The incidence of type 2 diabetes is highly correlated with obesity; however, there is a lack of research elucidating the temporal progression. Transgenic FVB/N...
nuclear receptors | diabète | obésité | lipotoxicity | lipotoxicité | récepteurs nucléaires | diabetes | obesity | Obesity | Diabetes | Lipotoxicity | Nuclear receptors | CAPACITY | SPORT SCIENCES | PHYSIOLOGY | LIPID-CONTENT | SENSITIVITY | BROWN ADIPOSE-TISSUE | HUMAN SKELETAL-MUSCLE | NUTRITION & DIETETICS | MUSCLE INSULIN-RESISTANCE | FATTY-ACID OXIDATION | TRANSGENIC MICE | Mitochondrial Dynamics | Prediabetic State - metabolism | Weaning | Mitochondria, Muscle - metabolism | Diet, High-Fat - adverse effects | Male | Muscle, Skeletal - metabolism | Diabetes Mellitus, Type 2 - metabolism | Obesity - blood | Adiposity | Hyperinsulinism - etiology | Time Factors | Diabetes Mellitus, Type 2 - etiology | Obesity - etiology | Prediabetic State - etiology | Weight Gain | Hyperinsulinism - blood | Hyperinsulinism - physiopathology | Hyperinsulinism - metabolism | Muscle, Skeletal - enzymology | Prediabetic State - blood | Reproducibility of Results | Mitochondria, Muscle - enzymology | Insulin Resistance | Mice, Transgenic | Obesity - physiopathology | Random Allocation | Disease Progression | Obesity - metabolism | Triglycerides - metabolism | Diabetes Mellitus, Type 2 - blood | Animals | Prediabetic State - physiopathology | Type 2 diabetes | Physiological aspects | Development and progression | Genetic aspects | Triglycerides | Research
nuclear receptors | diabète | obésité | lipotoxicity | lipotoxicité | récepteurs nucléaires | diabetes | obesity | Obesity | Diabetes | Lipotoxicity | Nuclear receptors | CAPACITY | SPORT SCIENCES | PHYSIOLOGY | LIPID-CONTENT | SENSITIVITY | BROWN ADIPOSE-TISSUE | HUMAN SKELETAL-MUSCLE | NUTRITION & DIETETICS | MUSCLE INSULIN-RESISTANCE | FATTY-ACID OXIDATION | TRANSGENIC MICE | Mitochondrial Dynamics | Prediabetic State - metabolism | Weaning | Mitochondria, Muscle - metabolism | Diet, High-Fat - adverse effects | Male | Muscle, Skeletal - metabolism | Diabetes Mellitus, Type 2 - metabolism | Obesity - blood | Adiposity | Hyperinsulinism - etiology | Time Factors | Diabetes Mellitus, Type 2 - etiology | Obesity - etiology | Prediabetic State - etiology | Weight Gain | Hyperinsulinism - blood | Hyperinsulinism - physiopathology | Hyperinsulinism - metabolism | Muscle, Skeletal - enzymology | Prediabetic State - blood | Reproducibility of Results | Mitochondria, Muscle - enzymology | Insulin Resistance | Mice, Transgenic | Obesity - physiopathology | Random Allocation | Disease Progression | Obesity - metabolism | Triglycerides - metabolism | Diabetes Mellitus, Type 2 - blood | Animals | Prediabetic State - physiopathology | Type 2 diabetes | Physiological aspects | Development and progression | Genetic aspects | Triglycerides | Research
Journal Article
Molecular Genetics and Metabolism, ISSN 1096-7192, 03/2017, Volume 120, Issue 3, pp. 198 - 206
This study documents the disparate therapeutic effect of -carbamyl- -glutamate (NCG) in the activation of two different disease-causing mutants of carbamyl...
Urea cycle disorder, mutations | Carbamyl phosphate synthetase 1 deficiency | Hyperammonemia | N-acetyl-l-glutamate | N-acetyl-L-glutamate | PROPIONIC ACIDEMIA | MEDICINE, RESEARCH & EXPERIMENTAL | ACETYLGLUTAMATE SYNTHASE DEFICIENCY | HYPERINSULINISM/HYPERAMMONEMIA SYNDROME | PHOSPHATE SYNTHETASE-I | RAT-LIVER MITOCHONDRIA | RECOMBINANT CPS1 | CARGLUMIC ACID | MAMMALIAN LIVER | ENDOCRINOLOGY & METABOLISM | GENETICS & HEREDITY | NEONATAL HYPERAMMONEMIA | METHYLMALONIC ACIDURIA | Protein Structure, Tertiary | Adenosine Triphosphate - administration & dosage | Humans | Rare Diseases - drug therapy | Male | Carbamoyl-Phosphate Synthase (Ammonia) - chemistry | Rare Diseases - enzymology | Adenosine Triphosphate - pharmacology | Animals | Carbamoyl-Phosphate Synthase I Deficiency Disease - drug therapy | Carbamoyl-Phosphate Synthase I Deficiency Disease - enzymology | Protein Stability - drug effects | Glutamates - pharmacology | Glutamates - administration & dosage | Female | Mice | Mutation | Drug Therapy, Combination | Carbamoyl-Phosphate Synthase (Ammonia) - genetics | Precision Medicine | Glutamate | Enzymes | Analysis | Phosphates | Urea | Amino acids | Ligases | Urea cycle disorder | mutations
Urea cycle disorder, mutations | Carbamyl phosphate synthetase 1 deficiency | Hyperammonemia | N-acetyl-l-glutamate | N-acetyl-L-glutamate | PROPIONIC ACIDEMIA | MEDICINE, RESEARCH & EXPERIMENTAL | ACETYLGLUTAMATE SYNTHASE DEFICIENCY | HYPERINSULINISM/HYPERAMMONEMIA SYNDROME | PHOSPHATE SYNTHETASE-I | RAT-LIVER MITOCHONDRIA | RECOMBINANT CPS1 | CARGLUMIC ACID | MAMMALIAN LIVER | ENDOCRINOLOGY & METABOLISM | GENETICS & HEREDITY | NEONATAL HYPERAMMONEMIA | METHYLMALONIC ACIDURIA | Protein Structure, Tertiary | Adenosine Triphosphate - administration & dosage | Humans | Rare Diseases - drug therapy | Male | Carbamoyl-Phosphate Synthase (Ammonia) - chemistry | Rare Diseases - enzymology | Adenosine Triphosphate - pharmacology | Animals | Carbamoyl-Phosphate Synthase I Deficiency Disease - drug therapy | Carbamoyl-Phosphate Synthase I Deficiency Disease - enzymology | Protein Stability - drug effects | Glutamates - pharmacology | Glutamates - administration & dosage | Female | Mice | Mutation | Drug Therapy, Combination | Carbamoyl-Phosphate Synthase (Ammonia) - genetics | Precision Medicine | Glutamate | Enzymes | Analysis | Phosphates | Urea | Amino acids | Ligases | Urea cycle disorder | mutations
Journal Article
Cellular Physiology and Biochemistry, ISSN 1015-8987, 12/2016, Volume 40, Issue 5, pp. 933 - 943
Background/Aims: Salvianolic acid B (Sal B), a major polyphenolic compound of Salvia miltiorrhiza Bunge, has been shown to possess potential antidiabetic...
Original Paper | AMPK | GLUT4 | PPARa | Type 2 Diabetes | Salvianolic acid B | APOPTOSIS | PHYSIOLOGY | ACTIVATED PROTEIN-KINASE | PPAR alpha | BIOLOGICAL-ACTIVITIES | MILTIORRHIZA | CELL BIOLOGY | PRODUCT | PHARMACOLOGY | ANIMAL-MODELS | CHEMISTRY | STREPTOZOTOCIN | EXPRESSION | Dyslipidemias - genetics | AMP-Activated Protein Kinases - metabolism | Dyslipidemias - complications | Glucose Transporter Type 4 - metabolism | Glycogen Synthase - metabolism | Gluconeogenesis - drug effects | Body Weight - drug effects | Hyperglycemia - complications | Benzofurans - pharmacology | Male | Hyperinsulinism - drug therapy | RNA, Messenger - metabolism | Glycolysis - drug effects | Hyperglycemia - drug therapy | Glucose Intolerance - blood | Hyperglycemia - genetics | Benzofurans - chemistry | Glucose Intolerance - drug therapy | Dyslipidemias - blood | Glycogen - metabolism | Liver - drug effects | Lipids - blood | Muscle, Skeletal - drug effects | Phosphorylation - drug effects | Hyperinsulinism - blood | Dyslipidemias - drug therapy | Glucose Intolerance - genetics | Muscle, Skeletal - enzymology | Benzofurans - therapeutic use | Hyperinsulinism - complications | Liver - metabolism | Mice, Inbred C57BL | RNA, Messenger - genetics | Pancreas - drug effects | Pancreas - pathology | Glucose Intolerance - complications | Gene Expression Regulation - drug effects | Animals | Hyperglycemia - blood | Signal Transduction - drug effects | Glucose - metabolism | PPAR alpha - metabolism | PPARα
Original Paper | AMPK | GLUT4 | PPARa | Type 2 Diabetes | Salvianolic acid B | APOPTOSIS | PHYSIOLOGY | ACTIVATED PROTEIN-KINASE | PPAR alpha | BIOLOGICAL-ACTIVITIES | MILTIORRHIZA | CELL BIOLOGY | PRODUCT | PHARMACOLOGY | ANIMAL-MODELS | CHEMISTRY | STREPTOZOTOCIN | EXPRESSION | Dyslipidemias - genetics | AMP-Activated Protein Kinases - metabolism | Dyslipidemias - complications | Glucose Transporter Type 4 - metabolism | Glycogen Synthase - metabolism | Gluconeogenesis - drug effects | Body Weight - drug effects | Hyperglycemia - complications | Benzofurans - pharmacology | Male | Hyperinsulinism - drug therapy | RNA, Messenger - metabolism | Glycolysis - drug effects | Hyperglycemia - drug therapy | Glucose Intolerance - blood | Hyperglycemia - genetics | Benzofurans - chemistry | Glucose Intolerance - drug therapy | Dyslipidemias - blood | Glycogen - metabolism | Liver - drug effects | Lipids - blood | Muscle, Skeletal - drug effects | Phosphorylation - drug effects | Hyperinsulinism - blood | Dyslipidemias - drug therapy | Glucose Intolerance - genetics | Muscle, Skeletal - enzymology | Benzofurans - therapeutic use | Hyperinsulinism - complications | Liver - metabolism | Mice, Inbred C57BL | RNA, Messenger - genetics | Pancreas - drug effects | Pancreas - pathology | Glucose Intolerance - complications | Gene Expression Regulation - drug effects | Animals | Hyperglycemia - blood | Signal Transduction - drug effects | Glucose - metabolism | PPAR alpha - metabolism | PPARα
Journal Article
The British journal of nutrition, ISSN 0007-1145, 2014, Volume 112, Issue 2, pp. 154 - 161
Exocrine pancreatic digestive enzymes are essential for the digestion of dietary components and are regulated by them. Chronic excess dietary high fat (HF)...
2 related proteins | insulin-resistance | expression | colipase | cholesterol absorption | lipase messenger-rna | cholecystokinin | adaptation | exocrine pancreas | rats | Obesity | Exocrine pancreas | Digestive enzymes | CHOLECYSTOKININ | RATS | LIPASE MESSENGER-RNA | 2 RELATED PROTEINS | CHOLESTEROL ABSORPTION | NUTRITION & DIETETICS | INSULIN-RESISTANCE | ADAPTATION | COLIPASE | EXPRESSION | Diet, High-Fat - adverse effects | Male | RNA, Messenger - metabolism | Phospholipases A2, Secretory - genetics | Leptin - blood | Hyperinsulinism - etiology | Obesity - etiology | Colipases - genetics | RNA Processing, Post-Transcriptional | Mice, Inbred C57BL | Insulin Resistance | Obesity - physiopathology | Lipase - metabolism | Random Allocation | Pancreas, Exocrine - enzymology | Obesity - metabolism | Gene Expression Regulation, Enzymologic | Animals | Hyperglycemia - etiology | Mice | Obesity - enzymology | Pancreas, Exocrine - metabolism | Pancreas, Exocrine - physiopathology | Phospholipases A2, Secretory - metabolism | Protein Processing, Post-Translational | Colipases - metabolism | Lipase - genetics | Enzymes | Nutrition research | Oils & fats | Rodents
2 related proteins | insulin-resistance | expression | colipase | cholesterol absorption | lipase messenger-rna | cholecystokinin | adaptation | exocrine pancreas | rats | Obesity | Exocrine pancreas | Digestive enzymes | CHOLECYSTOKININ | RATS | LIPASE MESSENGER-RNA | 2 RELATED PROTEINS | CHOLESTEROL ABSORPTION | NUTRITION & DIETETICS | INSULIN-RESISTANCE | ADAPTATION | COLIPASE | EXPRESSION | Diet, High-Fat - adverse effects | Male | RNA, Messenger - metabolism | Phospholipases A2, Secretory - genetics | Leptin - blood | Hyperinsulinism - etiology | Obesity - etiology | Colipases - genetics | RNA Processing, Post-Transcriptional | Mice, Inbred C57BL | Insulin Resistance | Obesity - physiopathology | Lipase - metabolism | Random Allocation | Pancreas, Exocrine - enzymology | Obesity - metabolism | Gene Expression Regulation, Enzymologic | Animals | Hyperglycemia - etiology | Mice | Obesity - enzymology | Pancreas, Exocrine - metabolism | Pancreas, Exocrine - physiopathology | Phospholipases A2, Secretory - metabolism | Protein Processing, Post-Translational | Colipases - metabolism | Lipase - genetics | Enzymes | Nutrition research | Oils & fats | Rodents
Journal Article
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, ISSN 0193-1857, 07/2016, Volume 311, Issue 1, pp. G50 - G58
Abnormal glucose metabolism is present in almost 40% of patients after acute pancreatitis, but its pathophysiology has been poorly investigated. Pancreatic...
PHYSIOLOGY | RISK-FACTORS | insulin | POLYPEPTIDE CONCENTRATIONS | ENDOCRINE | CLASSIFICATION | PREVALENCE | EXOCRINE | DIABETES-MELLITUS | acute pancreatitis | amylin | pancreatic polypeptide | SECRETION | ALCOHOLIC PANCREATITIS | GASTROENTEROLOGY & HEPATOLOGY | glucose metabolism | Multivariate Analysis | Glycated Hemoglobin A - metabolism | Humans | Middle Aged | Male | Pancreatitis - complications | Insulin - blood | Glucagon - blood | Pancreatic Hormones - blood | Hyperinsulinism - etiology | Fasting - blood | Adult | Female | Hyperinsulinism - blood | Acute Disease | Cross-Sectional Studies | Insulin Resistance | Linear Models | Biomarkers - blood | Chi-Square Distribution | Islet Amyloid Polypeptide - blood | Pancreatitis - diagnosis | Pancreatitis - enzymology | Pancreatic Polypeptide - blood | Somatostatin - blood | Pancreatitis - blood | Aged | Blood Glucose - metabolism
PHYSIOLOGY | RISK-FACTORS | insulin | POLYPEPTIDE CONCENTRATIONS | ENDOCRINE | CLASSIFICATION | PREVALENCE | EXOCRINE | DIABETES-MELLITUS | acute pancreatitis | amylin | pancreatic polypeptide | SECRETION | ALCOHOLIC PANCREATITIS | GASTROENTEROLOGY & HEPATOLOGY | glucose metabolism | Multivariate Analysis | Glycated Hemoglobin A - metabolism | Humans | Middle Aged | Male | Pancreatitis - complications | Insulin - blood | Glucagon - blood | Pancreatic Hormones - blood | Hyperinsulinism - etiology | Fasting - blood | Adult | Female | Hyperinsulinism - blood | Acute Disease | Cross-Sectional Studies | Insulin Resistance | Linear Models | Biomarkers - blood | Chi-Square Distribution | Islet Amyloid Polypeptide - blood | Pancreatitis - diagnosis | Pancreatitis - enzymology | Pancreatic Polypeptide - blood | Somatostatin - blood | Pancreatitis - blood | Aged | Blood Glucose - metabolism
Journal Article
American Journal of Clinical Pathology, ISSN 0002-9173, 06/2016, Volume 145, Issue 6, pp. 757 - 768
Objectives: To quantify islet cell nucleomegaly in controls and tissues obtained from patients with congenital hyperinsulinism in infancy (CHI) and to examine...
B cell | Hyperplasia | Islet | Congenital hyperinsulinism | Hypoglycemia | Nucleomegaly | Pancreas | Serial block-face scanning electron microscopy | Insulin | VISUALIZATION | beta cell | MANAGEMENT | BETA-CELLS | PHENOTYPE | PROLIFERATION | MECHANISMS | PATHOLOGY | CHILDREN | POSITRON-EMISSION-TOMOGRAPHY | ABCC8 GENE MUTATION | Congenital Hyperinsulinism - pathology | Islets of Langerhans - pathology | Cell Nucleus - pathology | Humans | Child, Preschool | Female | Infant | Male | Islets of Langerhans - ultrastructure | Cell Nucleus - ultrastructure | Microscopy, Electron | Infant, Newborn | β cell | Original
B cell | Hyperplasia | Islet | Congenital hyperinsulinism | Hypoglycemia | Nucleomegaly | Pancreas | Serial block-face scanning electron microscopy | Insulin | VISUALIZATION | beta cell | MANAGEMENT | BETA-CELLS | PHENOTYPE | PROLIFERATION | MECHANISMS | PATHOLOGY | CHILDREN | POSITRON-EMISSION-TOMOGRAPHY | ABCC8 GENE MUTATION | Congenital Hyperinsulinism - pathology | Islets of Langerhans - pathology | Cell Nucleus - pathology | Humans | Child, Preschool | Female | Infant | Male | Islets of Langerhans - ultrastructure | Cell Nucleus - ultrastructure | Microscopy, Electron | Infant, Newborn | β cell | Original
Journal Article
Diabetes, ISSN 0012-1797, 06/2016, Volume 65, Issue 6, pp. 1672 - 1678
Congenital hyperinsulinism of infancy (CHI) can be caused by inactivating mutations in the gene encoding short-chain 3-hydroxyacyl-CoA dehydrogenase (SCHAD), a...
CONGENITAL HYPERINSULINISM | OXIDATION | HYPERINSULINEMIC HYPOGLYCEMIA | 3-HYDROXYACYL-COA DEHYDROGENASE | INSULIN-SECRETION | ENDOCRINOLOGY & METABOLISM | BETA-CELL | MUTATIONS | RELEASE | Hypoglycemia - genetics | 3-Hydroxyacyl-CoA Dehydrogenase - deficiency | Hypoglycemia - enzymology | Congenital Hyperinsulinism - enzymology | Male | Mice, Knockout | Insulin - metabolism | Insulin-Secreting Cells - metabolism | Phenotype | Animals | Congenital Hyperinsulinism - genetics | Mice | Glutamate Dehydrogenase - metabolism | Insulin Secretion | Islet Studies
CONGENITAL HYPERINSULINISM | OXIDATION | HYPERINSULINEMIC HYPOGLYCEMIA | 3-HYDROXYACYL-COA DEHYDROGENASE | INSULIN-SECRETION | ENDOCRINOLOGY & METABOLISM | BETA-CELL | MUTATIONS | RELEASE | Hypoglycemia - genetics | 3-Hydroxyacyl-CoA Dehydrogenase - deficiency | Hypoglycemia - enzymology | Congenital Hyperinsulinism - enzymology | Male | Mice, Knockout | Insulin - metabolism | Insulin-Secreting Cells - metabolism | Phenotype | Animals | Congenital Hyperinsulinism - genetics | Mice | Glutamate Dehydrogenase - metabolism | Insulin Secretion | Islet Studies
Journal Article
The Journal of Nutritional Biochemistry, ISSN 0955-2863, 06/2016, Volume 32, pp. 115 - 122
Fructose intake from added sugars correlates with the epidemic rise in metabolic syndrome and related events. Nevertheless, consumption of beverages sweetened...
Pregnancy | Fructokinase | Fructose | Fetal programming | Dyslipidemia | METABOLIC SYNDROME | ALPHA GENE-EXPRESSION | BIOCHEMISTRY & MOLECULAR BIOLOGY | RATS | FATTY-ACIDS | OBESITY | NUTRITION & DIETETICS | INSULIN-RESISTANCE | FRUCTOKINASE EXPRESSION | LIVER | CHREBP | WEIGHT-GAIN | Beverages - adverse effects | Liver - enzymology | Maternal Nutritional Physiological Phenomena | Fatty Acids, Nonesterified - agonists | Non-alcoholic Fatty Liver Disease - etiology | Gene Expression Profiling | Triglycerides - agonists | Adiponectin - agonists | Basic Helix-Loop-Helix Leucine Zipper Transcription Factors - agonists | Non-alcoholic Fatty Liver Disease - blood | Nutritive Sweeteners - adverse effects | Dyslipidemias - blood | Hyperinsulinism - etiology | Fatty Acids, Nonesterified - blood | Female | Dyslipidemias - etiology | Hyperinsulinism - blood | Hyperinsulinism - physiopathology | Hyperinsulinism - metabolism | Glucose - adverse effects | Fructose - adverse effects | Liver - metabolism | Gene Expression Regulation | Fetal Development | Non-alcoholic Fatty Liver Disease - metabolism | Non-alcoholic Fatty Liver Disease - physiopathology | Random Allocation | Rats, Sprague-Dawley | Fructokinases - metabolism | Adiponectin - blood | Animals | Basic Helix-Loop-Helix Leucine Zipper Transcription Factors - genetics | Fructokinases - chemistry | Triglycerides - blood | Dyslipidemias - metabolism | Fructokinases - genetics | Basic Helix-Loop-Helix Leucine Zipper Transcription Factors - metabolism | Dyslipidemias - physiopathology | Pregnant women | Leptin | Protein binding | RNA | Glucose | Dextrose
Pregnancy | Fructokinase | Fructose | Fetal programming | Dyslipidemia | METABOLIC SYNDROME | ALPHA GENE-EXPRESSION | BIOCHEMISTRY & MOLECULAR BIOLOGY | RATS | FATTY-ACIDS | OBESITY | NUTRITION & DIETETICS | INSULIN-RESISTANCE | FRUCTOKINASE EXPRESSION | LIVER | CHREBP | WEIGHT-GAIN | Beverages - adverse effects | Liver - enzymology | Maternal Nutritional Physiological Phenomena | Fatty Acids, Nonesterified - agonists | Non-alcoholic Fatty Liver Disease - etiology | Gene Expression Profiling | Triglycerides - agonists | Adiponectin - agonists | Basic Helix-Loop-Helix Leucine Zipper Transcription Factors - agonists | Non-alcoholic Fatty Liver Disease - blood | Nutritive Sweeteners - adverse effects | Dyslipidemias - blood | Hyperinsulinism - etiology | Fatty Acids, Nonesterified - blood | Female | Dyslipidemias - etiology | Hyperinsulinism - blood | Hyperinsulinism - physiopathology | Hyperinsulinism - metabolism | Glucose - adverse effects | Fructose - adverse effects | Liver - metabolism | Gene Expression Regulation | Fetal Development | Non-alcoholic Fatty Liver Disease - metabolism | Non-alcoholic Fatty Liver Disease - physiopathology | Random Allocation | Rats, Sprague-Dawley | Fructokinases - metabolism | Adiponectin - blood | Animals | Basic Helix-Loop-Helix Leucine Zipper Transcription Factors - genetics | Fructokinases - chemistry | Triglycerides - blood | Dyslipidemias - metabolism | Fructokinases - genetics | Basic Helix-Loop-Helix Leucine Zipper Transcription Factors - metabolism | Dyslipidemias - physiopathology | Pregnant women | Leptin | Protein binding | RNA | Glucose | Dextrose
Journal Article
Acta Pharmaceutica, ISSN 1330-0075, 12/2015, Volume 65, Issue 4, pp. 443 - 452
Glutamate (Glu) is a major excitatory neurotransmitter involved in epilepsy. Glu is synthesized by glutamate dehydrogenase (GDH, E.C. 1.4.1.3) and dysfunction...
GABA | GDH | antiepileptics | oxygen consumption | glutamate | MOLECULAR TARGETS | DRUGS | HYPERINSULINISM-HYPERAMMONEMIA SYNDROME | PHARMACOLOGY & PHARMACY | EPILEPSY | Seizures - prevention & control | Brain - enzymology | Male | Anticonvulsants - pharmacology | Valproic Acid - pharmacology | Diazepam - pharmacology | Seizures - chemically induced | Seizures - physiopathology | Time Factors | Glutamate Dehydrogenase - antagonists & inhibitors | Phenytoin - pharmacology | Ketoglutaric Acids - metabolism | Glutamate Dehydrogenase - metabolism | Disease Models, Animal | Seizures - enzymology | Oxidation-Reduction | Brain - physiopathology | Enzyme Inhibitors - pharmacology | Oxygen Consumption | Brain - drug effects | Animals | Deamination | Glutamic Acid - metabolism | Mice | Pentylenetetrazole
GABA | GDH | antiepileptics | oxygen consumption | glutamate | MOLECULAR TARGETS | DRUGS | HYPERINSULINISM-HYPERAMMONEMIA SYNDROME | PHARMACOLOGY & PHARMACY | EPILEPSY | Seizures - prevention & control | Brain - enzymology | Male | Anticonvulsants - pharmacology | Valproic Acid - pharmacology | Diazepam - pharmacology | Seizures - chemically induced | Seizures - physiopathology | Time Factors | Glutamate Dehydrogenase - antagonists & inhibitors | Phenytoin - pharmacology | Ketoglutaric Acids - metabolism | Glutamate Dehydrogenase - metabolism | Disease Models, Animal | Seizures - enzymology | Oxidation-Reduction | Brain - physiopathology | Enzyme Inhibitors - pharmacology | Oxygen Consumption | Brain - drug effects | Animals | Deamination | Glutamic Acid - metabolism | Mice | Pentylenetetrazole
Journal Article
Journal of Clinical Lipidology, ISSN 1933-2874, 2015, Volume 9, Issue 5, pp. 664 - 675
Background Proprotein convertase subtilisin/kexin type 9 (PCSK9) shuttles low-density lipoprotein (LDL) receptors for degradation, thus upregulates LDL plasma...
Cardiovascular | adipose tissue | low-density lipoproteins | PCSK9 | Apolipoprotein B100 | type II diabetes mellitus | obesity | FAMILIAL HYPERCHOLESTEROLEMIA | LOW-DENSITY-LIPOPROTEIN | OXIDIZED LDL | APOLIPOPROTEIN-B | OBESE WOMEN | PROPROTEIN CONVERTASES | INSULIN-RESISTANCE | PHARMACOLOGY & PHARMACY | GLUCOSE-TOLERANCE | ADIPOSE-TISSUE | Humans | Middle Aged | Insulin Resistance | Metabolic Diseases - epidemiology | Male | Metabolic Diseases - blood | Risk | Apolipoproteins B - blood | Obesity - blood | Hypertriglyceridemia - blood | Chylomicrons - metabolism | Serine Endopeptidases - blood | Adipose Tissue, White - enzymology | Postprandial Period | Female | Proprotein Convertases - blood | Aged | Hyperinsulinism - blood | Lipoprotein Lipase - metabolism | Proprotein Convertase 9
Cardiovascular | adipose tissue | low-density lipoproteins | PCSK9 | Apolipoprotein B100 | type II diabetes mellitus | obesity | FAMILIAL HYPERCHOLESTEROLEMIA | LOW-DENSITY-LIPOPROTEIN | OXIDIZED LDL | APOLIPOPROTEIN-B | OBESE WOMEN | PROPROTEIN CONVERTASES | INSULIN-RESISTANCE | PHARMACOLOGY & PHARMACY | GLUCOSE-TOLERANCE | ADIPOSE-TISSUE | Humans | Middle Aged | Insulin Resistance | Metabolic Diseases - epidemiology | Male | Metabolic Diseases - blood | Risk | Apolipoproteins B - blood | Obesity - blood | Hypertriglyceridemia - blood | Chylomicrons - metabolism | Serine Endopeptidases - blood | Adipose Tissue, White - enzymology | Postprandial Period | Female | Proprotein Convertases - blood | Aged | Hyperinsulinism - blood | Lipoprotein Lipase - metabolism | Proprotein Convertase 9
Journal Article